SOX2 and synovial sarcoma: When rhTGF-β1 was at an appropriate concentration (10 ng/mL), the mRNA expression levels of SOX-2 and Nanog increased, but the expression levels of OCT-4 mRNA decreased, indicating that SOX-2 and Nanog are relatively sensitive to rhTGF-β1 treatment in SS.